NCT03986255

Brief Summary

This is a single center exploratory study in subjects suffering from chronic refractory pain to identify cellular, molecular and protein biomarkers within cerebrospinal fluid (CSF). The study aims to identify any form of correlation between biological content of CSF and pain/treatment success. The study population include individuals suffering from chronic pain which has not been effectively treated with pharmacological treatment, medical intervention or alternative non-invasive treatments who have been scheduled for spinal cord stimulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

March 19, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 14, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2021

Completed
Last Updated

June 12, 2024

Status Verified

June 1, 2024

Enrollment Period

2.8 years

First QC Date

February 27, 2019

Last Update Submit

June 11, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Pain VAS

    Visual Analogue Scale (VAS) used to assess improvements in pain. It is a continuous scale comprised of a horizontal line which is 10 centimeters (100mm) in length, anchored by 2 verbal descriptors, one which is no pain and the other worst imaginable pain. Lower scores denote a better outcome. Participants will be asked to complete this questionnaires at baseline and follow up visits.

    6 Months

  • Pain Map

    A pain checklist with a list of anatomical locations from which the participants selects relevant sites to the site of his/her pain. It is used to assess location of pain. Participants will be asked to complete this questionnaires at baseline and follow up visits.

    6 Months

  • Oswestry Disability Index (ODI)

    A self completed questionnaire used to assess changes in disability and health. The participants checks the statements which most closely resembles their situation. The scores for all the questions are summed with lower scores denote no disability. Participants will be asked to complete this questionnaires at baseline and follow up visits.

    6 Months

  • Patient Global Impression of Change (PGIC)

    Questionnaire used to assess patient satisfaction Participants will be asked to complete this questionnaires at follow up visits. .

    6 Months

  • Douleur Neuropathique 4 (DN4)

    A clinician-administered questionnaire consisting of 10 items. Seven items related to pain quality (i.e. sensory and pain descriptors) are based on an interview with the patient and 3 items based on the clinical examination. The questionnaire used to assess neuropathic pain Participants will be asked to complete this questionnaires at baseline and follow up visits.

    6 Months

  • EQ-5D-5L

    A self report questionnaire used to assess improvements in quality of life. Participants will be asked to complete this questionnaires at baseline and follow up visits.

    6 Months

  • Pittsburgh Sleep Quality Index (PSQI)

    A self report questionnaire that will used to assess improvements in sleep quality. The questionnaire consists of 19 items which measures several different aspects of sleep. Each item is weighted on a 0 - 3 interval scale, the overall score is calculated by totalling the seven component scores. Lower scores denote a healthier sleep quality Participants will be asked to complete this questionnaires at baseline and follow up visits.

    6 Months

Study Arms (1)

Lumbar Puncture

EXPERIMENTAL

Participants will undergo Lumbar puncture procedure

Procedure: Lumbar Puncture

Interventions

The participant is placed lateral or sitting position. Fluoroscopy may be used to guide sampling. Full aseptic technique is used throughout. The skin is prepared with either 2% chlorhexidine/70% alcohol or iodine. 1% lidocaine is used for skin local anesthesia an entry point is identified, this may be done using fluoroscopy. This will be at the lowest intervertebral foramina interspace to minimize the risk of spinal cord injury. A small amount to head up tilt will be allowed to optimize CSF flow. Sampling is done using a "needle through needle" technique. An epidural needle is used to identify the epidural space using loss of resistance to saline technique. A spinal needle (26G) is then passed through the epidural needle into the subarachnoid space. Correct entry is noted once CSF is noted in the needle hub and 5 ml taken. This sample is then sent off for analysis. Once the CSF is sampled, the needle is removed and pressure applied to the skin entry point.

Lumbar Puncture

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Be capable of understanding and signing a written consent form
  • Subjects suffering from chronic neuropathic pain which has not been effectively managed with pharmacotherapy, medical interventions or alternative non-invasive treatments
  • Pain VAS score ≥ 5 on more than 3 days a week at least over three months.
  • Subjects deemed a suitable candidate receive spinal cord stimulator device as determined by a pain management specialist
  • No known contraindication to spinal cord stimulation
  • Does not have an active systemic or local infection

You may not qualify if:

  • Structural abnormalities of the spine at L2-L3 that may impact study procedure
  • Severe scoliosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's and St Thomas Hospital

London, SE1 7EH, United Kingdom

Location

MeSH Terms

Conditions

Neuralgia

Interventions

Spinal Puncture

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BiopsySpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, NeurologicalPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2019

First Posted

June 14, 2019

Study Start

March 19, 2019

Primary Completion

December 20, 2021

Study Completion

December 20, 2021

Last Updated

June 12, 2024

Record last verified: 2024-06

Locations